Muhammad Asfandyar Nadir

Muhammad Asfandyar Nadir

Auto-generated profile, based on publicly available information

Muhammad Asfandyar Nadir

Department of Medicine, Allama Iqbal Medical College, Lahore, Pakistan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in Cardiovascular Toxicology
Verified
Journal Article
Closed access
PDF file
MSMuhammad Bilal Sardar
Muhammad Bilal Sardar
MRMohsin Raza
Mohsin Raza
AFAmmara Fayyaz
Ammara Fayyaz
MNMuhammad Asfandyar Nadir
Muhammad Asfandyar Nadir
ZNZain Ali Nadeem
Zain Ali Nadeem
MBMuhammad Babar
Muhammad Babar

26 February 2026 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
PDF file
SDShaikh Muhammad Daniyal
Shaikh Muhammad Daniyal
NKNaveen Murad Khatoon
Naveen Murad Khatoon
ARAnas Rasool
Anas Rasool
IGIsbah Gul
Isbah Gul
STSabula Tabish
Sabula Tabish
SASomaiya Ahmed
Somaiya Ahmed
Background: Sodium‐glucose cotransporter 2 (SGLT2) inhibitors improve cardiovascular (CV) outcomes in patients with heart failure (HF) and type 2 diabetes. Their effect in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS), however, remains unclear. This study evaluated whether SGLT2 inhibitors reduce all‐cause mortality and HF hospitalisations after TAVR. Methods: A systematic search of PubMed, ScienceDirect, Cochrane (CENTRAL), Scopus and Embase was performed through April 2025 for studies comparing post‐TAVR outcomes between SGLT2 inhibitor users and non‐users. Outcomes of interest included a composite of all‐cause mortality or heart failure (HF) hospitalisation, along with the individual components of all‐cause mortality and HF hospitalisation. All outcomes were extracted at 1 year. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using a random‐effects model. Heterogeneity was quantified using I 2 statistics. Analyses were conducted in R (version 4.4.2). Results: Three studies (1 RCT, 2 Observational) comprising 3187 patients met inclusion criteria. SGLT2 inhibitor use was associated with a reduced risk of the composite outcome (HR: 0.75; 95% CI: 0.65, 0.86; p < 0.01). Individually, therapy lowered all‐cause mortality (HR: 0.72; 95% CI: 0.53, 0.96; p = 0.03) and HF hospitalisations (HR: 0.74; 95% CI: 0.61, 0.90; p < 0.01). Conclusion: In patients with severe AS undergoing TAVR, SGLT2 inhibitors were associated with significant reductions in all‐cause mortality and HF hospitalisations. These findings suggest a promising role for SGLT2 inhibitors in improving post‐TAVR outcomes. However, given the limited data, larger randomised clinical trials are necessary to consolidate these findings. Trial Registration: CRD420251132729

31 March 2025 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
ARArmaghan Ur Rehman
Armaghan Ur Rehman
MNMuhammad Asfandyar Nadir
Muhammad Asfandyar Nadir
AFAriba Fida
Ariba Fida
MJMuhammad Sheheryar Javed
Muhammad Sheheryar Javed
TATalha Abbas
Talha Abbas
SASophia Ahmed
Sophia Ahmed

2 May 2025 in World Neurosurgery
Verified
Journal Article
Open access
MAMohammad Ashraf
Mohammad Ashraf
SASophia Ahmed
Sophia Ahmed
MNMuhammad Asfandyar Nadir
Muhammad Asfandyar Nadir
ZTZuha Tariq
Zuha Tariq
MIMahrukh Iqbal
Mahrukh Iqbal
CGConor S. Gillespie
Conor S. Gillespie
Real-time intraoperative imaging with neuronavigation is a valuable adjunct in the surgical management of intra-axial brain tumours. While intraoperative magnetic resonance imaging (iMRI) is the gold standard, recent advances in technology have explored the utility of intraoperative computed tomography (iCT) as an alternative. A systematic review was conducted by searching multiple databases, including MEDLINE, PubMed, Scopus, Cochrane Library, and Web of Science, for studies published from 1982 to 2024. Studies that evaluated the use of iCT in intra-axial brain tumour surgeries and reported on outcomes such as the extent of tumour resection (EOTR), residual tumour detection, and postoperative complications were included. Thirteen studies met the inclusion criteria. Overall, recent improvements in iCT's soft tissue imaging quality have increased its utility in intra-axial brain tumour surgeries. iCT was found to improve tumour resection accuracy in some instances, helping neurosurgeons detect residual tumours and refine surgical strategies. However, conclusions about its impact on long-term outcomes are limited by the lack of data on molecular tumour characteristics and adjuvant therapies. Further high-quality prospective work is needed to validate the role of iCT in improving key outcome parameters in neuro-oncology. Until then, iCT remains an adjunct whose use can be considered in select cases. Continued research on iCT is warranted to determine further indications in intra-axial brain tumour surgery.

14 February 2025 in Journal of Asthma
Verified
Journal Article
Closed access
SASophia Ahmed
Sophia Ahmed
MNMuhammad Asfandyar Nadir
Muhammad Asfandyar Nadir
AIAreej Iftikhar
Areej Iftikhar
HAHamza Ashraf
Hamza Ashraf
MAMohammad Ashraf
Mohammad Ashraf
Around 7.7% of Americans have asthma, including 20.2 million adults and 4.6 million children. This study examines asthma mortality trends and disparities across U.S. demographic and geographic groups from 1999 to 2020. A retrospective analysis was conducted using the CDC WONDER database to examine asthma-related deaths in the U.S. from 1999 to 2020. Age-adjusted mortality rates (AAMRs) and crude mortality rates (CMRs) per 100,000 were calculated. Trends and annual percent changes (APCs) were assessed overall and stratified by sex, race, region, and age. From 1999 to 2020, the U.S. recorded 221 161 asthma-related deaths (AAMR: 3.07), mostly in medical facilities. Mortality declined from 1999 to 2018 (APC: -1.53%) but surged from 2018 to 2020 (APC: 28.63%). Females, NH Blacks, and NH American Indians had the highest mortality rates. Older adults (≥65) had the greatest burden, with younger groups showing notable increases post-2018. Rural areas and the West reported slightly higher rates than urban and other regions. Hawaii and the District of Columbia had the highest AAMRs, while Florida and Nevada had the lowest. Asthma-related mortality in the U.S. declined until 2018 but sharply increased from 2018 to 2020, with rises across all demographic groups, regions, and settings. Females, NH Blacks, and older adults consistently had higher mortality rates, while younger age groups showed recent alarming increases. Targeted interventions are urgently needed to address inequities and recent mortality surges.

3 October 2025 in Medicine
Verified
Journal Article
Open access
MBMuhammad Babar
Muhammad Babar
MRMohsin Raza
Mohsin Raza
MNMuhammad Asfandyar Nadir
Muhammad Asfandyar Nadir
AFAriba Fida
Ariba Fida
IFIzzah Fayyaz
Izzah Fayyaz
RARaheel Ahmed
Raheel Ahmed
Peptic ulcer disease (PUD) is associated with severe complications such as hemorrhage and perforation, leading to high morbidity and mortality rates despite advancements in treatment. This study aims to evaluate the temporal and regional mortality trends of adults with PUD in the United States from 1999 to 2020, stratified by sex, race/ethnicity, age group, and geographic region. Utilizing death certificate data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research database, age-adjusted mortality rates (AAMRs) per 100,000 individuals were derived from crude mortality rates (CMRs). Trends in AAMRs were analyzed through annual percent change (APC) and average APC (AAPC) using Joinpoint regression (Joinpoint Regression Program, V5.0.2). From 1999 to 2020, a total of 37,471 deaths due to PUD were reported in the United States. The AAMR remained stable from 1999 to 2001 (APC: 0.59), followed by a sharp decline from 2001 to 2012 (APC: −11.79). After a period of stability from 2012 to 2018 (APC: 1.53), the trend reversed with an increase from 2018 to 2020 (APC: 8.45). Males had higher AAMR (0.84) than females (0.71). Non-Hispanic Whites had the highest AAMR (0.82), and Hispanics or Latinos the lowest (0.49), with an overall decrease in mortality rates across all racial groups, particularly among Non-Hispanic Black or African Americans. The West had the highest AAMR (0.87), and the Northeast the lowest (0.71), with all regions showing a downward trend. Rural areas exhibited a higher AAMR (0.86) compared to urban areas (0.76). Mortality was most concentrated among adults aged 85 years and older (CMR: 7.63), and the lowest CMR was recorded in the 25 to 54 years age group (0.16). Most deaths occurred in medical facilities (81.89%), followed by decedents’ homes (8.36%) and nursing homes/long-term care (3.85%). The District of Columbia (AAMR: 1.47) reported the highest AAMR, while New Jersey (0.59) had the lowest. Despite the overall decline, regional and demographic disparities remain, highlighting the need for continued efforts to address PUD-related mortality.